RXTHIGH SIGNALFINANCIAL10-K

RXT showed substantial improvement in operating losses while significantly reducing capital expenditures and maintaining cost discipline across R&D and SG&A functions.

The company achieved meaningful progress in loss reduction through disciplined expense management, though it remains deeply unprofitable with negative stockholders' equity exceeding $1 billion. The strategic pivot toward AI and regulated environments suggests management is repositioning for higher-value opportunities, but execution risk remains elevated given the company's financial position.

Comparing 2026-03-06 vs 2025-03-21View on EDGAR →
FINANCIAL ANALYSIS

RXT demonstrated notable operational improvement with substantially reduced operating losses and lower net losses, supported by meaningful reductions in SG&A and R&D expenses. Capital expenditures declined significantly to $60.8M, reflecting more conservative investment spending. However, the company's balance sheet remains stressed with negative stockholders' equity deepening to -$1.2B, declining cash reserves, and reduced current assets, indicating ongoing financial challenges despite operational progress.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+88.9%
-$909.1M-$100.7M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+73.7%
-$858.2M-$225.8M

Net income grew 73.7% — bottom-line growth signals improving overall business health.

Capital Expenditure
Cash Flow
-45.3%
$111.1M$60.8M

Capex reduced 45.3% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
-26.5%
$144.0M$105.8M

Cash decreased 26.5% — monitor burn rate and upcoming capital needs.

Stockholders Equity
Balance Sheet
-21.4%
-$1.0B-$1.2B

Equity decreased 21.4% — buybacks or losses reducing book value, monitor solvency ratios.

Current Assets
Balance Sheet
-16.3%
$618.8M$517.8M

Current assets declined 16.3% — monitor working capital adequacy and short-term liquidity.

SG&A Expense
P&L
-14.2%
$707.6M$607.1M

SG&A reduced 14.2% — improved cost efficiency or headcount reduction improving operating margins.

R&D Expense
P&L
-13.9%
$45.4M$39.1M

R&D spending cut 13.9% — could signal cost discipline or concerning reduction in innovation investment.

Accounts Receivable
Balance Sheet
-10.8%
$298.8M$266.5M

Receivables declined — improved collection efficiency or conservative revenue recognition.

LANGUAGE CHANGES
NEW — 2026-03-06
PRIOR — 2025-03-21
ADDED
On March 2, 2026, 246,914,399 shares of the registrant s common stock, par value $0.01 per share, were outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 51 Item 7A.
and its subsidiaries ASC Accounting Standards Codification ASC 420 Accounting Standards Codification No.
We serve as a trusted operator of the full technology stack, from governed private cloud infrastructure to AI deployed in production environments.
From edge to core to cloud, we design, integrate and operate the infrastructure, data foundations and software platforms required to deliver business outcomes with predictable cost, resilience, security and compliance.
+7 more — sign up free →
REMOVED
On March 17, 2025, 237,306,679 shares of the registrant s common stock, par value $0.01 per share, were outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 50 Item 7A.
and its subsidiaries Apollo Global Securities Apollo Global Securities, LLC ASC Accounting Standards Codification ASC 420 Accounting Standards Codification No.
Internal Revenue Service July 2021 Restructuring Plan Internal restructuring plan committed to on July 21, 2021 Just Analytics Just Analytics Pte.
We design, build, and operate our customers cloud environments across all major technology platforms, irrespective of technology stack or deployment model.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →